![Modulation of Hepatic Inflammatory Risk Markers of Cardiovascular Diseases by PPAR–α Activators | Arteriosclerosis, Thrombosis, and Vascular Biology Modulation of Hepatic Inflammatory Risk Markers of Cardiovascular Diseases by PPAR–α Activators | Arteriosclerosis, Thrombosis, and Vascular Biology](https://www.ahajournals.org/cms/asset/7fc63cde-5bdf-41b0-a580-4071844769b0/7ff2.jpg)
Modulation of Hepatic Inflammatory Risk Markers of Cardiovascular Diseases by PPAR–α Activators | Arteriosclerosis, Thrombosis, and Vascular Biology
![Regulation of peroxisome proliferator‐activated receptors (PPAR) α and ‐γ of rat brain astrocytes in the course of activation by toll‐like receptor agonists - Chistyakov - 2015 - Journal of Neurochemistry - Wiley Online Library Regulation of peroxisome proliferator‐activated receptors (PPAR) α and ‐γ of rat brain astrocytes in the course of activation by toll‐like receptor agonists - Chistyakov - 2015 - Journal of Neurochemistry - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/6c185d16-aae4-46c3-aa30-ce562e2241f3/jnc13101-fig-0008-m.jpg)
Regulation of peroxisome proliferator‐activated receptors (PPAR) α and ‐γ of rat brain astrocytes in the course of activation by toll‐like receptor agonists - Chistyakov - 2015 - Journal of Neurochemistry - Wiley Online Library
![Anti-inflammatory effects of an optimized PPAR-γ agonist via NF-κB pathway inhibition - ScienceDirect Anti-inflammatory effects of an optimized PPAR-γ agonist via NF-κB pathway inhibition - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0045206819315317-ga1.jpg)
Anti-inflammatory effects of an optimized PPAR-γ agonist via NF-κB pathway inhibition - ScienceDirect
![Frontiers | The Role of Peroxisome Proliferator-Activated Receptor Gamma and Atherosclerosis: Post-translational Modification and Selective Modulators Frontiers | The Role of Peroxisome Proliferator-Activated Receptor Gamma and Atherosclerosis: Post-translational Modification and Selective Modulators](https://www.frontiersin.org/files/Articles/826811/fphys-13-826811-HTML/image_m/fphys-13-826811-g001.jpg)
Frontiers | The Role of Peroxisome Proliferator-Activated Receptor Gamma and Atherosclerosis: Post-translational Modification and Selective Modulators
![Molecules | Free Full-Text | Is There a Future for PPARs in the Treatment of Neuropsychiatric Disorders? Molecules | Free Full-Text | Is There a Future for PPARs in the Treatment of Neuropsychiatric Disorders?](https://pub.mdpi-res.com/molecules/molecules-25-01062/article_deploy/html/images/molecules-25-01062-g001.png?1602298161)
Molecules | Free Full-Text | Is There a Future for PPARs in the Treatment of Neuropsychiatric Disorders?
![Frontiers | The Protective Effects of Peroxisome Proliferator-Activated Receptor Gamma in Cerebral Ischemia-Reperfusion Injury Frontiers | The Protective Effects of Peroxisome Proliferator-Activated Receptor Gamma in Cerebral Ischemia-Reperfusion Injury](https://www.frontiersin.org/files/Articles/588516/fneur-11-588516-HTML/image_m/fneur-11-588516-g001.jpg)
Frontiers | The Protective Effects of Peroxisome Proliferator-Activated Receptor Gamma in Cerebral Ischemia-Reperfusion Injury
![Frontiers | Crosstalk Between Peroxisome Proliferator-Activated Receptor Gamma and the Canonical WNT/β-Catenin Pathway in Chronic Inflammation and Oxidative Stress During Carcinogenesis Frontiers | Crosstalk Between Peroxisome Proliferator-Activated Receptor Gamma and the Canonical WNT/β-Catenin Pathway in Chronic Inflammation and Oxidative Stress During Carcinogenesis](https://www.frontiersin.org/files/Articles/348165/fimmu-09-00745-HTML/image_m/fimmu-09-00745-g001.jpg)
Frontiers | Crosstalk Between Peroxisome Proliferator-Activated Receptor Gamma and the Canonical WNT/β-Catenin Pathway in Chronic Inflammation and Oxidative Stress During Carcinogenesis
![Marine Drugs | Free Full-Text | An Algal Metabolite-Based PPAR-γ Agonist Displayed Anti-Inflammatory Effect via Inhibition of the NF-κB Pathway Marine Drugs | Free Full-Text | An Algal Metabolite-Based PPAR-γ Agonist Displayed Anti-Inflammatory Effect via Inhibition of the NF-κB Pathway](https://www.mdpi.com/marinedrugs/marinedrugs-17-00321/article_deploy/html/images/marinedrugs-17-00321-g006.png)
Marine Drugs | Free Full-Text | An Algal Metabolite-Based PPAR-γ Agonist Displayed Anti-Inflammatory Effect via Inhibition of the NF-κB Pathway
Nuclear Receptors as Targets for Drug Development: Crosstalk Between Peroxisome Proliferator-Activated Receptor γ and Cytokines
![Marine Drugs | Free Full-Text | The In Vitro and In Vivo Anti-Inflammatory Effects of a Phthalimide PPAR-γ Agonist Marine Drugs | Free Full-Text | The In Vitro and In Vivo Anti-Inflammatory Effects of a Phthalimide PPAR-γ Agonist](https://pub.mdpi-res.com/marinedrugs/marinedrugs-15-00007/article_deploy/html/images/marinedrugs-15-00007-ag.png?1569166585)
Marine Drugs | Free Full-Text | The In Vitro and In Vivo Anti-Inflammatory Effects of a Phthalimide PPAR-γ Agonist
![Frontiers | Peroxisome Proliferator-Activated Receptors: Experimental Targeting for the Treatment of Inflammatory Bowel Diseases Frontiers | Peroxisome Proliferator-Activated Receptors: Experimental Targeting for the Treatment of Inflammatory Bowel Diseases](https://www.frontiersin.org/files/Articles/493292/fphar-11-00730-HTML/image_m/fphar-11-00730-g001.jpg)
Frontiers | Peroxisome Proliferator-Activated Receptors: Experimental Targeting for the Treatment of Inflammatory Bowel Diseases
![Glitazones Activate PGC-1α Signaling via PPAR-γ: A Promising Strategy for Antiparkinsonism Therapeutics | ACS Chemical Neuroscience Glitazones Activate PGC-1α Signaling via PPAR-γ: A Promising Strategy for Antiparkinsonism Therapeutics | ACS Chemical Neuroscience](https://pubs.acs.org/cms/10.1021/acschemneuro.1c00085/asset/images/large/cn1c00085_0005.jpeg)
Glitazones Activate PGC-1α Signaling via PPAR-γ: A Promising Strategy for Antiparkinsonism Therapeutics | ACS Chemical Neuroscience
![The peroxisome proliferator-activated receptor γ agonist pioglitazone prevents NF-κB activation in cisplatin nephrotoxicity through the reduction of p65 acetylation via the AMPK-SIRT1/p300 pathway - ScienceDirect The peroxisome proliferator-activated receptor γ agonist pioglitazone prevents NF-κB activation in cisplatin nephrotoxicity through the reduction of p65 acetylation via the AMPK-SIRT1/p300 pathway - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0006295215007558-fx1.jpg)